Scott's appointment marks an exciting new chapter for our organization. Ron Kraus Post this"Scott's appointment marks an exciting new chapter for our organization," said Ron Kraus, CEO. "His strategic vision, strong business acumen, and unwavering commitment to client success makes him an outstanding addition to our leadership team. As we continue to amplify our impact in the industry, Scott's leadership will be key in advancing our commercial strategy and deepening our client relationships.""Joining Syner-G and Sequoia at this exciting stage is a tremendous opportunity," Bergeron said. "The team's dedication to scientific rigor, regulatory expertise, and client success deeply resonates with me. I'm looking forward to contributing to our next phase of growth and helping our clients accelerate the delivery of innovative therapies and healthcare solutions to patients worldwide."Bergeron holds an MBA in management and brings a diverse background spanning sales, clinical research, and regulatory strategy

"As we continue to grow and expand our capabilities, Chris' leadership will play a crucial role in ensuring we deliver exceptional value to our clients and partners." Ron Kraus